EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient’s Perspective

Jesús Pérez-Pérez, Sofía García-López, Tamara Fernández Valle, Cèlia Painous, Maria Rosa Querol-Pascual, Pedro J García Ruiz, Elena Bellosta Diago, Esther Cubo Delgado, Barbara Vives Pastor, María Carmen Peiró Villaplana, Idaira Martín Santana, Marta Blázquez Estrada und 6 weitere

Neurology and Therapy · 2025-02 · 14 (1) · 99-115

DOI: 10.1007/s40120-024-00655-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurology and Therapy, online erschienen am 07.10.2024. Verfasst von Jesús Pérez-Pérez und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Movement Disorders Unit, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Limited information is available on patients' experience living with Huntington's disease (HD). The primary objective of this study was to assess the health-related quality of life and well being of patients with HD. METHODS: A non-interventional, cross-sectional study was conducted in 17 hospitals-based movement disorders units in Spain. Patients aged ≥ 18 years, genetically HD diagnosed [with a diagnostic confidence level score of 4, and an Independence Scale (IS) score ≥ 70] were included. The primary variables were the Huntington's Disease Health-related Quality of Life (HDQLIFE) scores and results of the Satisfaction with Life Scale (SWLS). Secondary outcomes include the Unified HD Rating Scale (UHDRS), Beck Hopelessness Scale (BHS), Stigma Scale for Chronic Illness (SSCI-8), Beck Depression Inventory-Fast Screen (BDI-FS) and Problem Behaviours Assessment for HD short Version (PBA-S). RESULTS: A total of 102 patients were included. The mean age (SD) was 53.1 (12.1) years and 56% were male. Most of the patients (99.0%) showed motor symptoms (87.3%), behavioural and psychiatric disturbances (59.8%), or cognitive impairment (20.6%). HDQLIFE domain score means (SD) includes concern with death and dying 45.97 (9.60) end-of-life planning 37.91 (8.84), and meaning and purpose 44.74 (9.05). SWLS score mean was 24.25 (7.33). Depressive symptoms were found in 37.4% of patients and moderate-to-severe feelings of hopelessness in 32.9%. The prevalence of stigma was 55.9% (n = 57). CONCLUSION: HD impacted quality of life, with prevalent motor, psychiatric symptoms and cognitive impairment. Patient perspectives may provide complementary information to implement specific interventions.

Schlagwörter

Stichwörter der Autor:innen

DepressionHealth-related quality of lifeHuntington diseasePatient-reported outcomesSatisfaction with LifeStigma

Autor:innen und Institutionen

  • Department of Neurology, Movement Disorders Unit, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain.
  • Centro Investigación Biomedica en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
  • Medical Department, Roche Pharma, Madrid, Spain.
  • Department of Neurology, University Hospital Cruces, Neurodegenerative Disease Group Health Research Institute of Bizkaia (BioBizkaia), Neuroscience Department University of the Basque Country, Leioa, Spain.
  • Parkinson and Movement Disorders Unit, Neurology Service, Hospital Clínic Universitari, Barcelona, Spain.

Zitieren

APA

Pérez-Pérez, J., García-López, S., Valle, T. F., Painous, C., Querol-Pascual, M. R., Ruiz, P. J. G., Diago, E. B., Cubo Delgado, E., Pastor, B. V., Villaplana, M. C. P., Santana, I. M., Blázquez Estrada, M., Garride, M. C., Mir, P., Álvarez, C., Maurino, J., de Prado, A., & López-Sendón, J. L. (2025). Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient’s Perspective. Neurology and Therapy, 14(1), 99-115. https://doi.org/10.1007/s40120-024-00655-0

Vancouver

Pérez-Pérez J, García-López S, Valle TF, Painous C, Querol-Pascual MR, Ruiz PJG, et al. Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient’s Perspective. Neurology and Therapy. 2025;14(1):99-115. doi:10.1007/s40120-024-00655-0

BibTeX
@article{PrezPrez2025,
  author = {Pérez-Pérez, Jesús and García-López, Sofía and Valle, Tamara Fernández and Painous, Cèlia and Querol-Pascual, Maria Rosa and Ruiz, Pedro J García and Diago, Elena Bellosta and Cubo Delgado, Esther and Pastor, Barbara Vives and Villaplana, María Carmen Peiró and Santana, Idaira Martín and Blázquez Estrada, Marta and Garride, Matilde Calopa and Mir, Pablo and Álvarez, Carmen and Maurino, Jorge and de Prado, Anna and López-Sendón, José Luis},
  title = {Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient’s Perspective},
  journal = {Neurology and Therapy},
  year = {2025},
  volume = {14},
  number = {1},
  pages = {99--115},
  doi = {10.1007/s40120-024-00655-0}
}
Kostenlos starten →